The Community Oncology Alliance is suing the Trump administration in a bid to end “illegal” cuts which hamper cancer drug reimbursement, Fierce Healthcare reports.
The national nonprofit filed the lawsuit Wednesday in the U.S. District Court.
According to the report, the organization in their filing say the Centers for Medicare and Medicaid Services should discontinue its two percent cut to Medicare Part D drug reimbursement. The COA says using that cut to Part B reimbursement is both “illegal and unconstitutional.”
“What’s interesting about Part B drug reimbursement, as opposed to any other Medicare reimbursement, is that Medicare Part B reimbursement to physicians is defined in law,” COA Executive Director Ted Okon tells Fierce Healthcare. “It’s an overreach of the executive branch in terms of basically bypassing Congress.”
The rate, according to the report, is defined by statute in the Medicare Modernization Act of 2003.
Neither the U.S. Department of Health and Human Services nor the White House Office of Management and Budget, both of which are named in the suit, have responded to Fierce Healthcare’s request for comment.
To read the full report on Fierce Healthcare, click here.